Delivery Order SPE2DB20D3505-SPE2DB25FYCDK
- Not listed
- The Defense Logistics Agency awarded a $2,288.33 delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ZORYVE is a topical dermatological treatment used primarily for inflammatory skin conditions, and this delivery order reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZORYVE 0.3% Foam 60GM, a topical dermatological medication. This firm fixed price delivery order, valued at $1,158.98, represents a non-set-aside competitive award with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $2,424.17 under a firm fixed-price contract type. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,092.43 to supply ZORYVE 0.3% Foam in 60-gram units. This contract represents a child delivery order under a larger indefinite delivery contract vehicle, utilizing firm fixed-price pricing with no set-aside designation. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,457.92 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream (60 grams) on August 25, 2025, with completion expected by August 26, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania,...
- This delivery order, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on August 5, 2025, provides $1,113.09 in firm fixed price funding for ZORYVE 0.3% Foam 60gm, a pharmaceutical product to be delivered to the Conshohocken, Pennsylvania location with completion targeted for August 6, 2025. The award represents a non-competitive delivery order issued under an existing contract vehicle, reflecting DLA's established relationship with AmerisourceBergen as a critical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,166.99 contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCDKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of pharmaceutical product deliveries under its comprehensive DLA contract vehicle, which enables the supply of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This specific delivery order for ZORYVE dermatological foam represents one of numerous small-value transactions processed through the company's established relationship with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/3/25 |